Lumiaxiom vs Drata

Drata's core promise is continuous monitoring — polling integrations to check whether controls stayed passing. Lumiaxiom goes further: Continuous Operational Control means the platform doesn't just watch — it enforces, remediates, and records tamper-evidently across policy, code, and AI systems.

Continuous monitoring vs Continuous Operational Control

Continuous monitoring (Drata)

  • Polls cloud & HRIS integrations for state drift.
  • Alerts on failed checks; humans remediate manually.
  • Evidence stored as files; verified by vendor.
  • Framework-oriented (SOC 2 first).

Continuous Operational Control (Lumiaxiom)

  • Monitors policy, code, models, vendors, access — in one control plane.
  • Auto-remediation with PR drafts and guardrail enforcement.
  • Hash-chained ledger auditors can re-verify locally.
  • Risk-oriented across GRC + AI + code + data.

Feature comparison

CapabilityLumiaxiomDrata
SOC 2 / ISO 27001 / HIPAA
EU AI Act obligations Partial
NIST AI RMF mappings Partial
AI-BOM & model registry
Guardrails & red-team runners
PR-scan code compliance
Hash-chained evidence integrity
Continuous control monitoring
Live regulatory intel feeds Partial
Auto-remediation with PR drafts
Vendor risk questionnaires
Auditor read-only grants
Multi-tenant MSP mode
Public trust portal
Starter pricing$49/mo~$10k+/yr

When Drata is the right pick

  • Your risk surface is 100% SaaS — no AI, no shipped software, no regulated data flows.
  • You have a US-only auditor with a strong Drata relationship.
  • You need the widest possible consumer SaaS integration library.

When Lumiaxiom is the right pick

  • You ship AI features and need EU AI Act, ISO 42001, or NIST AI RMF evidence.
  • You want compliance enforced at code-commit time, not just observed.
  • You need tamper-evident evidence for financial services or health data.
  • You're a consultancy / MSP running programs for multiple clients.

See Continuous Operational Control in action

Start a workspace, connect one repo, and watch controls, evidence, and PRs update live.